Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-07-30

Clinical Trial Update: tDCS and Executive Function Training for Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating transcranial direct current stimulation (tDCS) with executive function training for schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Toronto | Conditions: Schizophrenia, Schizophrenia Spectrum Disorder | NA | Status: WITHDRAWN